Dr MATTHEW JONES's Outputs (4)

A dynamic, modifiable model for estimating cost-effectiveness of smoking cessation interventions in pregnancy: application to an RCT of self-help delivered by text message (2018)
Journal Article
Jones, M., Smith, M., Lewis, S., Parrott, S., & Coleman, T. (2019). A dynamic, modifiable model for estimating cost-effectiveness of smoking cessation interventions in pregnancy: application to an RCT of self-help delivered by text message. Addiction, 114(2), 353-365. https://doi.org/10.1111/add.14476

Background/Aims: Previous evaluations of smoking cessation interventions in pregnancy have several limitations. Our solution to these limitations is the Economics of Smoking in Pregnancy (ESIP) model which estimates the lifetime cost-effectiveness of... Read More about A dynamic, modifiable model for estimating cost-effectiveness of smoking cessation interventions in pregnancy: application to an RCT of self-help delivered by text message.

Uptake of Tailored Text Message Smoking Cessation Support in Pregnancy When Advertised on the Internet (MiQuit): Observational Study (2018)
Journal Article
Emery, J., Coleman, T., Sutton, S., Cooper, S., Leonardi-Bee, J., Jones, M. D., & Naughton, F. (2018). Uptake of Tailored Text Message Smoking Cessation Support in Pregnancy When Advertised on the Internet (MiQuit): Observational Study. Journal of Medical Internet Research, 20(4), Article e146. https://doi.org/10.2196/jmir.8525

Background: Smoking in pregnancy is a major public health concern. Pregnant smokers are particularly difficult to reach, with low uptake of support options and few effective interventions. Text message–based self-help is a promising, low-cost interve... Read More about Uptake of Tailored Text Message Smoking Cessation Support in Pregnancy When Advertised on the Internet (MiQuit): Observational Study.

Systematic review and meta-analysis to assess the safety of Buproprion and Varenicline in pregnancy (2018)
Journal Article
Turner, E., Coleman, T., Jones, M., & Vaz, L. (2018). Systematic review and meta-analysis to assess the safety of Buproprion and Varenicline in pregnancy. Nicotine and Tobacco Research, 21(8), 1001–1010. https://doi.org/10.1093/ntr/nty055

Introduction: Smoking in pregnancy is a substantial public health issue, but, apart from nicotine replacement therapy (NRT), pharmacological therapies are not generally used to promote cessation. Bupropion and varenicline are effective cessation meth... Read More about Systematic review and meta-analysis to assess the safety of Buproprion and Varenicline in pregnancy.

Estimating the healthcare costs of children born to pregnant smokers in England: cohort study using primary and secondary healthcare data (2018)
Journal Article
Vaz, L. R., Jones, M. J., Szatkowski, L., Tata, L. J., Petrou, S., & Coleman, T. (2018). Estimating the healthcare costs of children born to pregnant smokers in England: cohort study using primary and secondary healthcare data. Addiction, 113(7), 1305-1316. https://doi.org/10.1111/add.14183

Background and aims: Little is known about the long term economic consequences of smoking during pregnancy. We estimated the association between smoking in pregnancy and the costs of delivering healthcare to infants and children in England, and inves... Read More about Estimating the healthcare costs of children born to pregnant smokers in England: cohort study using primary and secondary healthcare data.